Serth J - Search Results

1

Tissue microarrays: applications in urological cancer research.

Merseburger AS, Anastasiadis AG, Hennenlotter J, Schilling D, Simon P, Machtens SA, Serth J, Stenzl A, Kuczyk MA. Merseburger AS, et al. Among authors: serth j. World J Urol. 2006 Nov;24(5):579-84. doi: 10.1007/s00345-006-0103-1. Epub 2006 Aug 9. World J Urol. 2006. PMID: 16896596 Review.

2

Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.

Horstmann M, Merseburger AS, von der Heyde E, Serth J, Wegener G, Mengel M, Feil G, Hennenlotter J, Nagele U, Anastasiadis A, Bokemeyer C, Stenzl A, Kuczyk M. Horstmann M, et al. Among authors: serth j. J Cancer Res Clin Oncol. 2005 Nov;131(11):715-22. doi: 10.1007/s00432-005-0019-y. Epub 2005 Nov 1. J Cancer Res Clin Oncol. 2005. PMID: 16080018

3

The need for microdissectional tumor cell preparation during the molecular genetic analysis of prostate cancer.

Kuczyk M, Serth J, Bokemeyer C, Machtens S, Schwede J, Herrmann R, Paeslack U, Truss MC, Knüchel R, Jonas U. Kuczyk M, et al. Among authors: serth j. World J Urol. 1999 Apr;17(2):115-22. doi: 10.1007/s003450050116. World J Urol. 1999. PMID: 10367371

4

PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activation.

Hennenlotter J, Ohneseit PA, Simon P, Merseburger AS, Serth J, Kuehs U, Kramer M, Hartmann JT, Stenzl A, Kuczyk MA. Hennenlotter J, et al. Among authors: serth j. Oncol Rep. 2008 May;19(5):1141-7. Oncol Rep. 2008. PMID: 18425369

5

Detection of P53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications.

Kuczyk MA, Serth J, Hervatin C, Arndt H, Derendorf L, Thon WF, Jonas U. Kuczyk MA, et al. Among authors: serth j. World J Urol. 1994;12(6):345-51. doi: 10.1007/BF00184117. World J Urol. 1994. PMID: 7881474

6

Expression of E-cadherin in primary prostate cancer: correlation with clinical features.

Kuczyk M, Serth J, Machtens S, Bokemeyer C, Bathke W, Stief C, Jonas U. Kuczyk M, et al. Among authors: serth j. Br J Urol. 1998 Mar;81(3):406-12. doi: 10.1046/j.1464-410x.1998.00539.x. Br J Urol. 1998. PMID: 9523661

7

The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy.

Kuczyk MA, Serth J, Bokemeyer C, Machtens S, Minssen A, Bathke W, Hartmann J, Jonas U. Kuczyk MA, et al. Among authors: serth j. Eur J Cancer. 1998 Apr;34(5):679-86. doi: 10.1016/s0959-8049(97)10112-5. Eur J Cancer. 1998. PMID: 9713274

8

Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.

Merseburger AS, Serth J, von der Heyde E, Kobierski A, Wegener U, Mengel M, Jonas U, Kuczyk M. Merseburger AS, et al. Among authors: serth j. Urol Int. 2007;79(2):164-9. doi: 10.1159/000106332. Urol Int. 2007. PMID: 17851288

9

[Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].

Waalkes S, Merseburger AS, Simon A, Serth J, Kuczyk MA. Waalkes S, et al. Among authors: serth j. Urologe A. 2010 Mar;49(3):387-91. doi: 10.1007/s00120-009-2175-1. Urologe A. 2010. PMID: 20238481 German.

10

Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma.

Eggers H, Steffens S, Grosshennig A, Becker JU, Hennenlotter J, Stenzl A, Merseburger AS, Kuczyk MA, Serth J. Eggers H, et al. Among authors: serth j. Int J Oncol. 2012 May;40(5):1650-8. doi: 10.3892/ijo.2012.1367. Epub 2012 Feb 10. Int J Oncol. 2012. PMID: 22327210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page